BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1937208)

  • 1. [Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts].
    Shehab S; Leitner L; Bogokowsky B; Epstein I; Swartz TA
    Harefuah; 1991 Jun; 120(11):641-3. PubMed ID: 1937208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.
    Schwartz B; Al-Tobaiqi A; Al-Ruwais A; Fontaine RE; A'ashi J; Hightower AW; Broome CV; Music SI
    Lancet; 1988 Jun; 1(8597):1239-42. PubMed ID: 2897515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections.
    Schwartz B
    Rev Infect Dis; 1991; 13 Suppl 2():S170-3. PubMed ID: 2017647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the sanative action of rifampicin on the meningococcal carrier state].
    Deviatkina NP; Demina AA; Orlova EV; Timina VP; Petrova IS
    Antibiotiki; 1978 Sep; 23(9):794-7. PubMed ID: 100048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis.
    Simmons G; Jones N; Calder L
    J Antimicrob Chemother; 2000 Jun; 45(6):909-11. PubMed ID: 10837450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004785. PubMed ID: 17054214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In brief: Meningococcal prophylaxis.
    Med Lett Drugs Ther; 2008 Apr; 50(1283):25. PubMed ID: 18391897
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of rifampicin in healthy carriers of "N. meningitidis" (author's transl)].
    Delia S; Mauro A; Miceli MT
    Ann Sclavo; 1978; 20(5):675-80. PubMed ID: 111629
    [No Abstract]   [Full Text] [Related]  

  • 9. Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin.
    Cuevas LE; Kazembe P; Mughogho GK; Tillotson GS; Hart CA
    J Infect Dis; 1995 Mar; 171(3):728-31. PubMed ID: 7876629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Failure of chemoprophylaxis due to resistance of Neisseria meningitidis to rifampicin].
    Bordessoule A; Hoppé A; Ringuier B; Giniès JL
    Arch Pediatr; 2007 Jan; 14(1):99-100. PubMed ID: 17145173
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotics for preventing meningococcal infections.
    Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2011 Aug; (8):CD004785. PubMed ID: 21833949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does eradication of meningococcal carriage in household contacts prevent secondary cases of meningococcal disease?
    Stuart JM; Cartwright KA; Robinson PM; Noah ND
    BMJ; 1989 Mar; 298(6673):569-70. PubMed ID: 2495116
    [No Abstract]   [Full Text] [Related]  

  • 13. The chemoprophylaxis of cerebrospinal meningitis using rifampin in a military population.
    Chapalain JC; Guibourdenche M; Perrier-Gros-Claude JD; Bartoli M; Riou JY
    Pathol Biol (Paris); 1992 Mar; 40(3):230-3. PubMed ID: 1608666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice. Prevention of meningococcal disease.
    Gardner P
    N Engl J Med; 2006 Oct; 355(14):1466-73. PubMed ID: 17021322
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of rifampin in treatment of meningococcal carriers.
    Deal WB; Sanders E
    N Engl J Med; 1969 Sep; 281(12):641-5. PubMed ID: 4980025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Meningococcal disease in 2 siblings--failure of rifampicin prophylaxis].
    Kolmos HJ; Grytter C; Lind I
    Ugeskr Laeger; 1987 Nov; 149(48):3267-8. PubMed ID: 3124322
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics for preventing meningococcal infections.
    Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004785. PubMed ID: 24163051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.